Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec vs Glargine vs NPH in Toddlers with T1D
NCT04664764Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Feb 2019
- Primary completion
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin degludec in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Ain Shams University. Primary endpoints: Glycosylated Hemoglobin at 6 months and Frequency of Hypoglycemic Episodes at 6 months. Status: unknown.
02
Drugs
insulin degludec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04664764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664764.